KAVL
Kaival Brands Innovations Group, Inc.0.1806
+0.0211+13.2%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
2.09MP/E (TTM)
-Basic EPS (TTM)
-0.61Dividend Yield
0%Recent Filings
8-K
8-K
8-K
Nasdaq grants compliance extension
Kaival Brands Innovations Group snagged a 180-day Nasdaq extension on October 2, 2025, pushing its bid price compliance deadline to March 30, 2026, after failing the $1 minimum rule flagged in April. The company plans a reverse stock split if needed to lift its stock above $1 for 10 straight business days. Trading under KAVL persists uninterrupted. Delisting looms without success.
8-K
Merger with Delta terminated
Kaival Brands Innovations Group terminated its merger agreement with Delta Corp Holdings Limited on September 11, 2025, scrapping the business combination announced last year. The mutual deal includes full releases from all claims, fees, and liabilities tied to the merger, plus a six-month ban on Delta trading KAVL stock or contacting key stakeholders. Deal's dead. This clears the deck but leaves Kaival to navigate growth solo amid regulatory hurdles in vaping.
10-Q
Q3 FY2025 results
Kaival Brands Innovations Group posted Q3 FY2025 revenue of $142K, down sharply from $714K a year ago, as product sales halted amid ITC patent claims and FDA hurdles on Bidi Stick imports. Royalty income from the PMI international license fell to $142K from $441K, yet gross margins hit 100% with zero cost of revenue. Operating expenses dropped to $701K from $1.8M, mainly from lower professional fees, but a $708K ROU asset loss and $2.9M YTD stock-based comp pushed net loss to $559K, or $0.05 per share on 11.5M diluted shares—wider than last year's $1.6M loss yet milder per share thanks to more shares. Cash dwindled to $1.3M after $2.0M operating outflow, with no debt but $767K lease liability under negotiation; the terminated Delta merger leaves focus on GoFire IP monetization. Regulatory scrutiny on ENDS products lingers as a key risk.
BTI
British American Tobacco Indus
57.29-0.45
CHUC
Charlie's Holdings, Inc.
0.18+0.01
KGKG
KONA GOLD BEVERAGE INC.
0.00+0.00
MO
Altria Group, Inc.
59.33+0.24
PM
Philip Morris International Inc
157.95-0.46
RLX
RLX Technology Inc.
2.37-0.03
SBEV
Splash Beverage Group, Inc. (NV
1.12-0.04
TOBAF
TAAT Global Alternatives Inc.
0.04+0.00
TPB
Turning Point Brands, Inc.
110.86+1.25
VPRB
VPR Brands, LP
0.02+0.00